Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Which part of the AI trade is more likely to better serve investors?
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
Justin Trudeau has forked over $3.1 million for an expansive estate in Montreal's exclusive Outremont neighborhood-and got the seal of approval from girlfr...
The home, inspired by Kubrick's 2001 movie "Space Odyssey" is located in a highly sought-after neighborhood of Hollywood Hills, but has been on the market...
Honeywell International on Monday received a 26% discount on its deal to acquire a business tied to the struggling chemicals industry.
Novo Nordisk shares plunge after obesity drug falls short of rival in trial
This ETF invests aggressively in high-growth stocks, while maintaining minimal exposure to worse-performing areas of the market.
The financing forms part of a wider $1.75bn funding package authorised by US Bankruptcy Judge Alfredo Perez during a hearing in Houston.
Johnson Matthey shares sink 15% as Honeywell trims deal to GBP1.33 bln
Ahold Delhaize downgraded to accumulate by KBC Securities
US ambassador urges Portugal to buy F-35s, join top-tier air forces
Two investment funds said they would offer investors in a locked up private credit fund an exit - but at a hefty discount.
Is UK housing set for policy-driven upside? Barclays maintains top picks